Addressing the obesity challenge in plastic surgery – the role of liraglutide

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F23%3AS0000007" target="_blank" >RIV/00064211:_____/23:S0000007 - isvavai.cz</a>
Result on the web
<a href="https://www.prolekare.cz/casopisy/acta-chirurgiae-plasticae/2023-2-26/addressing-the-obesity-challenge-in-plastic-surgery-the-role-of-liraglutide-135202" target="_blank" >https://www.prolekare.cz/casopisy/acta-chirurgiae-plasticae/2023-2-26/addressing-the-obesity-challenge-in-plastic-surgery-the-role-of-liraglutide-135202</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Addressing the obesity challenge in plastic surgery – the role of liraglutide
Original language description
As obesity rates continue to rise globally, health risks and implications for surgical outcomes cannot be overlooked. Obesity increases mortality and morbidity and impairs health-related quality of life. Particularly concerning is that obese patients undergoing plastic surgery face a significantly higher risk of complications (11.3% absolute risk increase), particularly deep vein thrombosis and pulmonary embolism, and reoperations. These findings, summarized in a recent meta-analysis, underline the urgent need for plastic surgeons not only to understand obesity's impact on surgical outcomes but also to acquaint themselves with obesity treatment modalities, ranging from behavioural interventions and pharmacotherapy to bariatric surgery.
Czech name
—
Czech description
—

Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30212 - Surgery

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)